Adults with psoriasis saw significant improvement in their disease severity while adopting a Mediterranean diet.

Patients with HS had an increased risk of anxiety and new-onset depression that was not directly linked to disease severity.

Investigators uncovered key risk factors for disease recurrence in AD patients after dupilumab discontinuation.

Findings from a new study examining pediatric HS found patients experience a delay in diagnosis.

Lebrikizumab is effective in treating head and neck atopic dermatitis and erythema at 16 weeks of treatment.

Skin cancer risk may be associated with higher levels of serum 25(OH)D.

Patients with more severe chronic hand eczema were willing to dedicate a substantial amount of time daily for treatment

Treating PsO with adalimumab and concomitant methotrexate has no difference in effectiveness and persistence when compared to adalimumab monotherapy.